Halfdanarson, T. R., Wahl, R. L., Sukrithan, V., Mancini, B. R., Mosallaie, S. A., Balaraman, S., Sibley, G., Starr, J. S., Anthony, L. B., Liao, C., Mehr, S., Weiss, J., Ramirez, R. A., Iravani, A. I., Baratto, L., Yang, W., Hanna, A., Keefe, S. M., Puhlmann, M., Prasad, V. (2026). Cohort-level safety and efficacy results for [
                    <sup>212</sup>
                    Pb]VMT-α-NET in advanced somatostatin receptor subtype 2 (SSTR2+)–expressing neuroendocrine tumors (NETs): Cohorts 1–3.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4173